Increased urinary tribulin output in generalised anxiety disorder
- 1 July 1988
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 95 (3) , 378-380
- https://doi.org/10.1007/bf00181951
Abstract
Urinary output of an endogenous monoamine oxidase inhibitor and benzodiazepine receptor binding inhibitor (tribulin) was raised in a group of patients with generalised anxiety disorder compared with controls. Tribulin levels remained relatively constant in individual patients over the 6-week period of observation, mean values remaining high even after reduction of anxiety following non-drug behaviour therapy.Keywords
This publication has 17 references indexed in Scilit:
- Distribution of endogenous benzodiazepine receptor ligand-monoamine oxidase inhibitory activity (tribulin) in tissuesLife Sciences, 1986
- Purification and characterization of tribulin, an endogenous inhibitor of monoamine oxidase and of benzodiazepine receptor bindingJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1986
- Neurobiological mechanisms in human anxiety evidence supporting central noradrenergic hyperactivityNeuropharmacology, 1983
- New endogenous benzodiazepine receptor ligand in human urine: Identity with endogenous monoamine oxidase inhibitor?Life Sciences, 1983
- SEVERE ANXIETY INDUCED BY FG 7142, A β-CARBOLINE LIGAND FOR BENZODIAZEPINE RECEPTORSPublished by Elsevier ,1983
- ANXIETYThe Lancet, 1982
- Urinary Monoamine Oxidase Inhibitor and Benzodiazepine WithdrawalThe British Journal of Psychiatry, 1982
- Urinary MAO inhibitor in psychiatric illnessPsychiatry Research, 1981
- Benzodiazepines reduce stress-augmented increase in rat urine monoamine oxidase inhibitorNature, 1981
- THE ASSESSMENT OF ANXIETY STATES BY RATINGPsychology and Psychotherapy: Theory, Research and Practice, 1959